Literature DB >> 26081835

Proteomic Identification of Cysteine Cathepsin Substrates Shed from the Surface of Cancer Cells.

Barbara Sobotič1, Matej Vizovišek1, Robert Vidmar1, Petra Van Damme2, Vasilena Gocheva3, Johanna A Joyce3, Kris Gevaert2, Vito Turk4, Boris Turk5, Marko Fonović6.   

Abstract

Extracellular cysteine cathepsins are known to drive cancer progression, but besides degradation of extracellular matrix proteins little is known about their physiological substrates and thus the molecular mechanisms they deploy. One of the major mechanisms used by other extracellular proteases to facilitate cancer progression is proteolytic release of the extracellular domains of transmembrane proteins or ectodomain shedding. Here we show using a mass spectrometry-based approach that cathepsins L and S act as sheddases and cleave extracellular domains of CAM adhesion proteins and transmembrane receptors from the surface of cancer cells. In cathepsin S-deficient mouse pancreatic cancers, processing of these cathepsin substrates is highly reduced, pointing to an essential role of cathepsins in extracellular shedding. In addition to influencing cell migration and invasion, shedding of surface proteins by extracellular cathepsins impacts intracellular signaling as demonstrated for regulation of Ras GTPase activity, thereby providing a putative mechanistic link between extracellular cathepsin activity and cancer progression. The MS data is available via ProteomeXchange with identifier PXD002192.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26081835      PMCID: PMC4528248          DOI: 10.1074/mcp.M114.044628

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  79 in total

1.  Systematic comparison of label-free, metabolic labeling, and isobaric chemical labeling for quantitative proteomics on LTQ Orbitrap Velos.

Authors:  Zhou Li; Rachel M Adams; Karuna Chourey; Gregory B Hurst; Robert L Hettich; Chongle Pan
Journal:  J Proteome Res       Date:  2012-02-16       Impact factor: 4.466

2.  Probing the efficiency of proteolytic events by positional proteomics.

Authors:  Kim Plasman; Petra Van Damme; Dion Kaiserman; Francis Impens; Kimberly Demeyer; Kenny Helsens; Marc Goethals; Phillip I Bird; Joël Vandekerckhove; Kris Gevaert
Journal:  Mol Cell Proteomics       Date:  2010-11-03       Impact factor: 5.911

Review 3.  Proteolytic networks in cancer.

Authors:  Steven D Mason; Johanna A Joyce
Journal:  Trends Cell Biol       Date:  2011-01-12       Impact factor: 20.808

4.  Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice.

Authors:  Lisa Sevenich; Uta Schurigt; Kathrin Sachse; Mieczyslaw Gajda; Fee Werner; Sebastian Müller; Olga Vasiljeva; Anne Schwinde; Nicole Klemm; Jan Deussing; Christoph Peters; Thomas Reinheckel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-21       Impact factor: 11.205

Review 5.  Dual contrasting roles of cysteine cathepsins in cancer progression: apoptosis versus tumour invasion.

Authors:  Olga Vasiljeva; Boris Turk
Journal:  Biochimie       Date:  2007-10-18       Impact factor: 4.079

Review 6.  L1 cell adhesion molecule (L1CAM) in invasive tumors.

Authors:  Shani Raveh; Nancy Gavert; Avri Ben-Ze'ev
Journal:  Cancer Lett       Date:  2009-01-13       Impact factor: 8.679

7.  IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion.

Authors:  Vasilena Gocheva; Hao-Wei Wang; Bedrick B Gadea; Tanaya Shree; Karen E Hunter; Alfred L Garfall; Tara Berman; Johanna A Joyce
Journal:  Genes Dev       Date:  2010-01-15       Impact factor: 11.361

8.  Shedding of soluble epidermal growth factor receptor (sEGFR) is mediated by a metalloprotease/fibronectin/integrin axis and inhibited by cetuximab.

Authors:  Jason A Wilken; Marianela Perez-Torres; Rene Nieves-Alicea; Elsa M Cora; Trace A Christensen; Andre T Baron; Nita J Maihle
Journal:  Biochemistry       Date:  2013-06-21       Impact factor: 3.162

9.  Kinetics of the pH-induced inactivation of human cathepsin L.

Authors:  B Turk; I Dolenc; V Turk; J G Bieth
Journal:  Biochemistry       Date:  1993-01-12       Impact factor: 3.162

10.  The role of immunoglobulin superfamily cell adhesion molecules in cancer metastasis.

Authors:  Chee Wai Wong; Danielle E Dye; Deirdre R Coombe
Journal:  Int J Cell Biol       Date:  2012-01-09
View more
  35 in total

1.  Long-term endurance training increases serum cathepsin S levels in healthy female subjects.

Authors:  M Sponder; C Minichsdorfer; I-A Campean; M Emich; M Fritzer-Szekeres; B Litschauer; J Strametz-Juranek
Journal:  Ir J Med Sci       Date:  2017-11-27       Impact factor: 1.568

Review 2.  Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments.

Authors:  Stefan F Lichtenthaler; Marius K Lemberg; Regina Fluhrer
Journal:  EMBO J       Date:  2018-07-05       Impact factor: 11.598

3.  Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts.

Authors:  Sam L Ivry; Jeremy M Sharib; Dana A Dominguez; Nilotpal Roy; Stacy E Hatcher; Michele T Yip-Schneider; C Max Schmidt; Randall E Brand; Walter G Park; Matthias Hebrok; Grace E Kim; Anthony J O'Donoghue; Kimberly S Kirkwood; Charles S Craik
Journal:  Clin Cancer Res       Date:  2017-04-19       Impact factor: 12.531

4.  Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells.

Authors:  Catera L Wilder; Charlene Walton; Valencia Watson; Fermin A A Stewart; Jade Johnson; Shelly R Peyton; Christine K Payne; Valerie Odero-Marah; Manu O Platt
Journal:  Int J Biochem Cell Biol       Date:  2016-08-31       Impact factor: 5.085

Review 5.  Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.

Authors:  Oakley C Olson; Johanna A Joyce
Journal:  Nat Rev Cancer       Date:  2015-12       Impact factor: 60.716

6.  Cathepsin Protease Controls Copper and Cisplatin Accumulation via Cleavage of the Ctr1 Metal-binding Ectodomain.

Authors:  Helena Öhrvik; Brandon Logeman; Boris Turk; Thomas Reinheckel; Dennis J Thiele
Journal:  J Biol Chem       Date:  2016-05-03       Impact factor: 5.157

Review 7.  Cathepsin E expression and activity: Role in the detection and treatment of pancreatic cancer.

Authors:  Corbin Pontious; Sabrina Kaul; Marcus Hong; Phil A Hart; Somashekar G Krishna; Luis F Lara; Darwin L Conwell; Zobeida Cruz-Monserrate
Journal:  Pancreatology       Date:  2019-09-20       Impact factor: 3.996

8.  Platform to Discover Protease-Activated Antibiotics and Application to Siderophore-Antibiotic Conjugates.

Authors:  Jonathan H Boyce; Bobo Dang; Beatrice Ary; Quinn Edmondson; Charles S Craik; William F DeGrado; Ian B Seiple
Journal:  J Am Chem Soc       Date:  2020-12-10       Impact factor: 15.419

9.  Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells.

Authors:  Janja Završnik; Miha Butinar; Mojca Trstenjak Prebanda; Aleksander Krajnc; Robert Vidmar; Marko Fonović; Anders Grubb; Vito Turk; Boris Turk; Olga Vasiljeva
Journal:  Oncotarget       Date:  2017-04-24

10.  Peptide profiling in cow urine reveals molecular signature of physiology-driven pathways and in-silico predicted bioactive properties.

Authors:  Rohit Kumar; Syed Azmal Ali; Sumit Kumar Singh; Vanya Bhushan; Jai Kumar Kaushik; Ashok Kumar Mohanty; Sudarshan Kumar
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.